Track the CareRx Corporation share price and the full insider trade history of the company, a listed equity based in Canada. Shares trade on CA CA, under the supervision of SEDI. Market capitalisation: €212.5m. The latest transaction was disclosed on 6 August 2026 (38 - Redemption, retraction, cancellation, repurchase). Among the most active insiders: CareRx Corporation. All data is accessible without an account.
In the past 90 days, CareRx Corporation reported a total of 112 insider trading declarations, with a sum of €241,469 in purchases and no sales. The top insiders include CareRx Corporation itself, which made purchases totaling €241,469 across 46 declarations, followed by Jeff Watson and Kevin Dalton, both serving as Directors of the Issuer, with respective totals of €67,383 and €46,585 from 11 declarations each. The most notable declarations occurred on June 1, 2026, involving multiple insiders receiving grants of rights, including Jeff Watson, Bruce Stirling Moody, Ralph Desando, and Kevin Dalton, each with amounts around €31,373. Additionally, on July 3, 2026, CareRx Corporation executed a buy transaction for €17,315 related to redemption and repurchase activities.
Auto-generated summary, refreshed daily.Updated 1d ago
112
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CareRx Corporation Strong Buy (bullish), based on 7 analysts. Average price target: CA$5.14.
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 5,120 of 28,169 companies
67.9
score / 100
Value
77
Quality
58
FCF yld11%
Earn yld12%
EV/EBITDA10.2x
ROE27%
Gross mgn30%
Net mgn7.1%
Debt/EBITDA2.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
41 shares@ CA$3.510.0001% mcap0.3% of flowDeferred Share UnitsTSXSEDI:4751703
25 of 112 declarations
About CareRx Corporation
CareRx Corporation is a Canadian company that specializes in providing pharmacy services for healthcare. It focuses on residents in long-term care and community care.